Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mary Eapen, Mei-Jie Zhang et al.|Journal of Clinical Oncology|2017Cited by 325
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxisMahasweta Gooptu, Mary Eapen, Rizwan Romee et al.|Blood|2021Cited by 163
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis CongenitaShahinaz M. Gadalla, Sharon A. Savage, Carmem Sales‐Bonfim et al.|Biology of Blood and Marrow Transplantation|2013Cited by 130
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R. McCurdy, Mary Eapen, Mei-Jie Zhang et al.|Blood Advances|2018Cited by 96
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and OutcomesRachel Phelan, Mukta Arora, Min Chen et al.|Transplantation and Cellular Therapy|2022Cited by 82